Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Okahara

2422Nanoparticle-Mediated Delivery of Toll-Like Receptor 4 Antagonist to Monocytes and Ischemic Myocardium Enhances Cardioprotection Against Ischemia-Reperfusion Injury in Mice

European Heart Journal
Cardiovascular MedicineCardiology
2018English

Related publications

Toll-Like Receptor 4 Is Protective Against Neonatal Murine Ischemia-Reperfusion Intestinal Injury

Journal of Pediatric Surgery
MedicineChild HealthSurgeryPediatricsPerinatology
2010English

Alveolar Macrophages and Toll-Like Receptor 4 Mediate Ventilated Lung Ischemia Reperfusion Injury in Mice

Anesthesiology
AnesthesiologyPain Medicine
2012English

MicroRNA-421 Improves Ischemia/Reperfusion Injury via Regulation Toll-Like Receptor 4 Pathway

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Impact of Toll-Like Receptor 4 Deficiency on the Response to Uterine Ischemia/Reperfusion in Mice

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2013English

Protease-Activated Receptor 4 Deficiency Offers Cardioprotection After Acute Ischemia Reperfusion Injury

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2016English

On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Nanoparticle-Mediated Targeting of Cyclosporine a Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening

Scientific Reports
Multidisciplinary
2016English

Toll-Like Receptor 4 Antagonist Attenuates Intracerebral Hemorrhage–Induced Brain Injury

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2013English

Toll-Like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury Through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy